| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 138, 129-140, Copyright © 1991 by American Society for Investigative Pathology
REGULAR ARTICLES |
BJ Nickoloff, GD Karabin, JN Barker, CE Griffiths, V Sarma, RS Mitra, JT Elder, SL Kunkel and VM Dixit
Department of Pathology, University of Michigan Medical School, Ann Arbor.
The importance of immunologic mechanisms in psoriasis has been deduced from the ability of immunosuppressive therapies to ameliorate this common and chronic skin disease. Certainly the histology of psoriatic lesions suggests a dialogue between the hyperplastic keratinocytes and infiltrating T lymphocytes and macrophages. To begin dissecting the cytokine network involved in the pathophysiology of psoriasis, the location, in both epidermal and dermal compartments, of tumor necrosis factor-alpha, interleukin-8, intercellular adhesion molecule-1, and transforming growth factor-alpha at the protein and/or mRNA levels were identified. Tumor necrosis factor-alpha was selected as a potentially key regulatory cytokine, first because it induces cultured keratinocyte interleukin-8, intercellular adhesion molecule-1, and transforming growth factor-alpha production, and second because intercellular adhesion molecule-1 expression by keratinocytes in psoriatic epidermis had been identified previously. Using immunohistochemical localization, tumor necrosis factor-alpha was identified in 12 psoriatic lesions as intense and diffuse expression by dermal dendrocytes (macrophages) in the papillary dermis (without significant staining of endothelial cells, mast cells, or dermal Langerhans cells), and focally by keratinocytes and intraepidermal Langerhans cells. Functional interaction between the dermal dendrocytes and keratinocytes was suggested by the presence of interleukin-8 expression of suprabasal keratinocytes immediately above the tumor necrosis factor-alpha- positive dermal dendrocytes. Interleukin-8 mRNA and transforming growth factor-alpha mRNA were detectable in the epidermal roof of psoriatic lesions, but neither was detectable at the protein or mRNA levels in any normal skin specimens. Treatment of cultured human keratinocytes with phorbol ester (which experimentally produces psoriasiform changes on mouse skin) or tumor necrosis factor-alpha also increased interleukin-8 and transforming growth factor-alpha mRNAs. Further elucidation of the cellular and molecular basis for the genesis and evolution of psoriasis will provide the framework for a better evaluation of the cause and treatment of this skin disease.
This article has been cited by other articles:
![]() |
W. Gonsiorek, X. Fan, D. Hesk, J. Fossetta, H. Qiu, J. Jakway, M. Billah, M. Dwyer, J. Chao, G. Deno, et al. Pharmacological Characterization of Sch527123, a Potent Allosteric CXCR1/CXCR2 Antagonist J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 477 - 485. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cumberbatch, M. Singh, R. J. Dearman, H. S. Young, I. Kimber, and C. E.M. Griffiths Impaired Langerhans cell migration in psoriasis J. Exp. Med., April 17, 2006; 203(4): 953 - 960. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Johansen, A. T. Funding, K. Otkjaer, K. Kragballe, U. B. Jensen, M. Madsen, L. Binderup, T. Skak-Nielsen, M. S. Fjording, and L. Iversen Protein Expression of TNF-{alpha} in Psoriatic Skin Is Regulated at a Posttranscriptional Level by MAPK-Activated Protein Kinase 2 J. Immunol., February 1, 2006; 176(3): 1431 - 1438. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Kucharzik, J T Hudson III, A Lugering, J A Abbas, M Bettini, J G Lake, M E Evans, T R Ziegler, D Merlin, J L Madara, et al. Acute induction of human IL-8 production by intestinal epithelium triggers neutrophil infiltration without mucosal injury Gut, November 1, 2005; 54(11): 1565 - 1572. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Boyman, H. P. Hefti, C. Conrad, B. J. Nickoloff, M. Suter, and F. O. Nestle Spontaneous Development of Psoriasis in a New Animal Model Shows an Essential Role for Resident T Cells and Tumor Necrosis Factor-{alpha} J. Exp. Med., March 1, 2004; 199(5): 731 - 736. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Krueger and K. Callis Potential of Tumor Necrosis Factor Inhibitors in Psoriasis and Psoriatic Arthritis Arch Dermatol, February 1, 2004; 140(2): 218 - 225. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Leonardi, J. L. Powers, R. T. Matheson, B. S. Goffe, R. Zitnik, A. Wang, A. B. Gottlieb, and the Etanercept Psoriasis Study Group Etanercept as Monotherapy in Patients with Psoriasis N. Engl. J. Med., November 20, 2003; 349(21): 2014 - 2022. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bruch-Gerharz, O. Schnorr, C. Suschek, K.-F. Beck, J. Pfeilschifter, T. Ruzicka, and V. Kolb-Bachofen Arginase 1 Overexpression in Psoriasis: Limitation of Inducible Nitric Oxide Synthase Activity as a Molecular Mechanism for Keratinocyte Hyperproliferation Am. J. Pathol., January 1, 2003; 162(1): 203 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Miller, V. G. Pillarisetty, A. B. Shah, S. Lahrs, Z. Xing, and R. P. DeMatteo Endogenous Granulocyte-Macrophage Colony-Stimulating Factor Overexpression In Vivo Results in the Long-Term Recruitment of a Distinct Dendritic Cell Population with Enhanced Immunostimulatory Function J. Immunol., September 15, 2002; 169(6): 2875 - 2885. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. O'Quinn and J. L. Miller The Effectiveness of Tumor Necrosis Factor {alpha} Antibody (Infliximab) in Treating Recalcitrant Psoriasis: A Report of 2 Cases Arch Dermatol, May 1, 2002; 138(5): 644 - 648. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Homey, M.-C. Dieu-Nosjean, A. Wiesenborn, C. Massacrier, J.-J. Pin, E. Oldham, D. Catron, M. E. Buchanan, A. Muller, R. deWaal Malefyt, et al. Up-Regulation of Macrophage Inflammatory Protein-3{alpha}/CCL20 and CC Chemokine Receptor 6 in Psoriasis J. Immunol., June 15, 2000; 164(12): 6621 - 6632. [Abstract] [Full Text] [PDF] |
||||
![]() |
C M Arroyo, R J Schafer, E M Kurt, C A Broomfield, and A J Carmichael Response of normal human keratinocytes to sulfur mustard (HD): cytokine release using a non-enzymatic detachment procedure Human and Experimental Toxicology, January 1, 1999; 18(1): 1 - 11. [Abstract] [PDF] |
||||
![]() |
T. W. Wakefield, R. M. Strieter, C. A. Wilke, A. M. Kadell, S. K. Wrobleski, M. D. Burdick, R. Schmidt, S. L. Kunkel, and L. J. Greenfield Venous Thrombosis–Associated Inflammation and Attenuation With Neutralizing Antibodies to Cytokines and Adhesion Molecules Arterioscler. Thromb. Vasc. Biol., February 1, 1995; 15(2): 258 - 268. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |